ABOS Acumen Pharmaceuticals Inc
- Stocks
- Healthcare
- NASDAQ: ABOS
Price (delayed)
$2.03
Market cap
$122.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.28
Enterprise value
$115.8M
Relative Growth:
Rel. Growth:
0
Relative Strength:
Rel. Strength:
84
Relative Valuation:
Rel. Valuation:
N/A
Relative Profitability:
Rel. Profitability:
1
Highlights
Acumen Pharmaceuticals's net income has plunged by 111% YoY and by 18% from the previous quarter
Acumen Pharmaceuticals's EPS has plunged by 104% YoY and by 18% from the previous quarter
Key stats
What are the main financial stats of ABOS
Market
Valuations
Earnings
Shares outstanding
60.57M
Market cap
$122.96M
Enterprise value
$115.8M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.05
Price to sales (P/S)
N/A
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$143.98M
Net income
-$136.67M
EBIT
-$132.53M
EBITDA
-$132.35M
Free cash flow
-$117.85M
Per share
Balance sheet
Liquidity
EPS
-$2.28
EPS diluted
-$2.28
Free cash flow per share
-$1.95
Book value per share
$1.93
Revenue per share
$0
TBVPS
$2.84
Total assets
$171.9M
Total liabilities
$54.82M
Debt
$29.88M
Equity
$117.08M
Working capital
$123.54M
Debt to equity
0.26
Current ratio
5.97
Quick ratio
5.78
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-62%
Return on equity
-81.4%
Return on invested capital
-68.6%
Return on capital employed
-90.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ABOS stock price
How has the Acumen Pharmaceuticals stock price performed over time
Intraday
4.64%
1 week
-10.18%
1 month
17.34%
1 year
-32.33%
YTD
18.02%
QTD
18.71%
Financial performance
How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$143.98M
Net income
-$136.67M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's net income has plunged by 111% YoY and by 18% from the previous quarter
Acumen Pharmaceuticals's operating income has shrunk by 88% YoY and by 14% QoQ
Price vs fundamentals
How does ABOS's price correlate with its fundamentals
Growth
What is Acumen Pharmaceuticals's growth rate over time
Valuation
What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.05
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has plunged by 104% YoY and by 18% from the previous quarter
The P/B is 75% more than the last 4 quarters average of 0.6 and 5% more than the 5-year quarterly average of 1.0
The company's equity has shrunk by 52% YoY and by 25% QoQ
Efficiency
How efficient is Acumen Pharmaceuticals business performance
ABOS's ROA has dropped by 183% year-on-year and by 33% since the previous quarter
ABOS's ROIC has plunged by 164% YoY and by 33% from the previous quarter
ABOS's return on equity is down by 40% since the previous quarter
Dividends
What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ABOS.
Financial health
How did Acumen Pharmaceuticals financials performed over time
ABOS's current ratio has dropped by 66% year-on-year and by 26% since the previous quarter
The company's quick ratio has shrunk by 66% YoY and by 25% QoQ
The company's debt is 74% lower than its equity
The debt to equity has soared by 117% YoY and by 37% from the previous quarter
The company's equity has shrunk by 52% YoY and by 25% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.